This is a prospective, non-randomized, multicenter, pivotal Investigational Device Exemption (IDE) study. The intent of this study is to demonstrate the safety and effectiveness of the ST Monitoring Feature in St Jude Medical ICD systems.
This is a prospective, non-randomized, multicenter, pivotal IDE study. The intent of this study is to demonstrate the safety and effectiveness of the ST Monitoring Feature in the Fortify® ST, Fortify Assura® ST, and Ellipse® ST family of devices, as well as any future St Jude Medical devices with the same ST Monitoring Feature capabilities. Effectiveness of the device will be evaluated by analyzing the sensitivity of the ST Monitoring Feature to detect clinical events. In addition, safety of the ST Monitoring Feature will be evaluated by demonstrating a low percentage of patients with false positive events.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
2,258
Algorithm for detecting ST changes that may be indicative of an acute coronary syndrome.
Number of Patients Who Experience a False Positive ST Detection in 12 Months FU
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cardiovascular Associates PC
Birmingham, Alabama, United States
Cardiovascular Associates PC
Birmingham, Alabama, United States
University Hospital - Univ. of Alabama at Birmingham (UAB)
Birmingham, Alabama, United States
Heart Center Research, LLC
Huntsville, Alabama, United States
Banner Heart Hospital
Mesa, Arizona, United States
Arizona Arrhythmia Research Center
Phoenix, Arizona, United States
Carondelet Specialist Group - Southwest Heartr
Tucson, Arizona, United States
Arkansas Cardiology
Little Rock, Arkansas, United States
Arkansas Heart Hospital
Little Rock, Arkansas, United States
Central Cardiology
Bakersfield, California, United States
...and 87 more locations